Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.JHP Pharmaceuticals, a developer, manufacturer and seller of pharmaceutical products, has named Stuart Hinchen as the new CEO of the company who will succeed Peter Jenkins, effective 1 July 2011.
Subscribe to our email newsletter
Prior to that Hinchen was the president and chief operating officer of JHP since the formation of the company in 2007.
Hinchen said JHP has a wonderful opportunity over the coming years to actively redefine the generic injectable competitive landscape in the USA.
"Peter remains a valued architect of our business development efforts and how we progress the company through future growth," Hinchen said.